Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck and Samsung's Humira biosimilar comes through in Phase III
Merck and Samsung's Humira biosimilar comes through in Phase III
Merck and Samsung's Humira biosimilar comes through in Phase III
Submitted by
admin
on July 8, 2015 - 9:23am
Source:
Fierce Biotech
News Tags:
Merck
Humira
biosimilars
SB5
Samsung Bioepis
AbbVie
rheumatoid arthritis
Headline:
Merck and Samsung's Humira biosimilar comes through in Phase III
Do Not Allow Advertisers to Use My Personal information
